307 related articles for article (PubMed ID: 33607266)
21. A simple, quick, and efficient CRISPR/Cas9 genome editing method for human induced pluripotent stem cells.
Geng BC; Choi KH; Wang SZ; Chen P; Pan XD; Dong NG; Ko JK; Zhu H
Acta Pharmacol Sin; 2020 Nov; 41(11):1427-1432. PubMed ID: 32555510
[TBL] [Abstract][Full Text] [Related]
22. Generation of an Induced Pluripotent Stem Cell Line with the Constitutive EGFP Reporter.
Butterfield KT; McGrath PS; Han CM; Kogut I; Bilousova G
Methods Mol Biol; 2020; 2155():11-21. PubMed ID: 32474864
[TBL] [Abstract][Full Text] [Related]
23. Fluorescent labeling of CRISPR/Cas9 RNP for gene knockout in HSPCs and iPSCs reveals an essential role for GADD45b in stress response.
Nasri M; Mir P; Dannenmann B; Amend D; Skroblyn T; Xu Y; Schulze-Osthoff K; Klimiankou M; Welte K; Skokowa J
Blood Adv; 2019 Jan; 3(1):63-71. PubMed ID: 30622144
[TBL] [Abstract][Full Text] [Related]
24. Efficient, footprint-free human iPSC genome editing by consolidation of Cas9/CRISPR and piggyBac technologies.
Wang G; Yang L; Grishin D; Rios X; Ye LY; Hu Y; Li K; Zhang D; Church GM; Pu WT
Nat Protoc; 2017 Jan; 12(1):88-103. PubMed ID: 27929521
[TBL] [Abstract][Full Text] [Related]
25. Rapid Generation of Human Genetic Loss-of-Function iPSC Lines by Simultaneous Reprogramming and Gene Editing.
Tidball AM; Dang LT; Glenn TW; Kilbane EG; Klarr DJ; Margolis JL; Uhler MD; Parent JM
Stem Cell Reports; 2017 Sep; 9(3):725-731. PubMed ID: 28781079
[TBL] [Abstract][Full Text] [Related]
26. Integration of xeno-free single-cell cloning in CRISPR-mediated DNA editing of human iPSCs improves homogeneity and methodological efficiency of cellular disease modeling.
Namipashaki A; Pugsley K; Liu X; Abrehart K; Lim SM; Sun G; Herold MJ; Polo JM; Bellgrove MA; Hawi Z
Stem Cell Reports; 2023 Dec; 18(12):2515-2527. PubMed ID: 37977144
[TBL] [Abstract][Full Text] [Related]
27. Fast and Efficient Generation of Isogenic Induced Pluripotent Stem Cell Lines Using Adenine Base Editing.
Nami F; Ramezankhani R; Vandenabeele M; Vervliet T; Vogels K; Urano F; Verfaillie C
CRISPR J; 2021 Aug; 4(4):502-518. PubMed ID: 34406036
[TBL] [Abstract][Full Text] [Related]
28. Homozygous might be hemizygous: CRISPR/Cas9 editing in iPSCs results in detrimental on-target defects that escape standard quality controls.
Simkin D; Papakis V; Bustos BI; Ambrosi CM; Ryan SJ; Baru V; Williams LA; Dempsey GT; McManus OB; Landers JE; Lubbe SJ; George AL; Kiskinis E
Stem Cell Reports; 2022 Apr; 17(4):993-1008. PubMed ID: 35276091
[TBL] [Abstract][Full Text] [Related]
29. CRISPR Del/Rei: a simple, flexible, and efficient pipeline for scarless genome editing.
Feuer KL; Wahbeh MH; Yovo C; Rabie E; Lam AN; Abdollahi S; Young LJ; Rike B; Umamageswaran A; Avramopoulos D
Sci Rep; 2022 Jul; 12(1):11928. PubMed ID: 35831384
[TBL] [Abstract][Full Text] [Related]
30. Using CRISPR-Cas9 to Generate Gene-Corrected Autologous iPSCs for the Treatment of Inherited Retinal Degeneration.
Burnight ER; Gupta M; Wiley LA; Anfinson KR; Tran A; Triboulet R; Hoffmann JM; Klaahsen DL; Andorf JL; Jiao C; Sohn EH; Adur MK; Ross JW; Mullins RF; Daley GQ; Schlaeger TM; Stone EM; Tucker BA
Mol Ther; 2017 Sep; 25(9):1999-2013. PubMed ID: 28619647
[TBL] [Abstract][Full Text] [Related]
31. Generation of a ST3GAL3 null mutant induced pluripotent stem cell (iPSC) line (UKWMPi002-A-3) by CRISPR/Cas9 genome editing.
Diouf D; Vitale MR; Zöller JEM; Pineau AM; Klopocki E; Hamann C; Ziegler GC; Vanmierlo T; Van den Hove D; Lesch KP
Stem Cell Res; 2023 Mar; 67():103038. PubMed ID: 36746102
[TBL] [Abstract][Full Text] [Related]
32. Lipofection-Based Delivery of CRISPR/Cas9 Ribonucleoprotein for Gene Editing in Male Germline Stem Cells.
Obermeier M; Rogiers V; Vanhaecke T; Baert Y
Methods Mol Biol; 2024; 2770():123-134. PubMed ID: 38351451
[TBL] [Abstract][Full Text] [Related]
33. Packaging and Uncoating of CRISPR/Cas Ribonucleoproteins for Efficient Gene Editing with Viral and Non-Viral Extracellular Nanoparticles.
Mazurov D; Ramadan L; Kruglova N
Viruses; 2023 Mar; 15(3):. PubMed ID: 36992399
[TBL] [Abstract][Full Text] [Related]
34. ASSURED-optimized CRISPR protocol for knockout/SNP knockin in hiPSCs.
Ludwik KA; Telugu N; Schommer S; Stachelscheid H; Diecke S
STAR Protoc; 2023 Sep; 4(3):102406. PubMed ID: 37481731
[TBL] [Abstract][Full Text] [Related]
35. Gene Editing in Green Alga Chlamydomonas reinhardtii via CRISPR-Cas9 Ribonucleoproteins.
Kelterborn S; Boehning F; Sizova I; Baidukova O; Evers H; Hegemann P
Methods Mol Biol; 2022; 2379():45-65. PubMed ID: 35188655
[TBL] [Abstract][Full Text] [Related]
36. Protocol for assessment of the efficiency of CRISPR/Cas RNP delivery to different types of target cells.
Tyumentseva MA; Tyumentsev AI; Akimkin VG
PLoS One; 2021; 16(11):e0259812. PubMed ID: 34752487
[TBL] [Abstract][Full Text] [Related]
37. CRISPR-Cas Gene Perturbation and Editing in Human Induced Pluripotent Stem Cells.
van Essen M; Riepsaame J; Jacob J
CRISPR J; 2021 Oct; 4(5):634-655. PubMed ID: 34582693
[TBL] [Abstract][Full Text] [Related]
38. Generation of two induced pluripotent stem cell lines (TMOi001-A-5, TMOi001-A-6) carrying variants in DISC1 exon 2 using CRISPR/Cas9 gene editing.
Heider J; Sperlich D; Vogel S; Breitmeyer R; Volkmer H
Stem Cell Res; 2022 Oct; 64():102925. PubMed ID: 36154917
[TBL] [Abstract][Full Text] [Related]
39. A high efficiency precision genome editing method with CRISPR in iPSCs.
Singh A; Smedley GD; Rose JG; Fredriksen K; Zhang Y; Li L; Yuan SH
Sci Rep; 2024 Apr; 14(1):9933. PubMed ID: 38688988
[TBL] [Abstract][Full Text] [Related]
40. Efficient bi-allelic tagging in human induced pluripotent stem cells using CRISPR.
Ren X; Takagi MA; Shen Y
STAR Protoc; 2023 Mar; 4(1):102084. PubMed ID: 36853689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
